Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

1011506

registered interest
date	21/11/2018
answering body	Department for Environment, Food and Rural Affairs
answering dept id	13
answering dept short name	Environment, Food and Rural Affairs
answering dept sort name	Environment, Food and Rural Affairs
hansard heading	Potatoes: Sales
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Environment, Food and Rural Affairs, with reference to the Farmers' Guardian article Major seed potato market could be killed off with no-deal Brexit, published on 13 August 2018, what information his Department holds on the legality of selling sell seed potatoes to EU countries after March 2019 in the event that the UK leaves the EU without a deal.
tabling member constituency	Berwick-upon-Tweed
tabling member printed	Anne-Marie Trevelyan
uin	194154
answer	answer is ministerial correction date of answer 28/11/2018 answer text <p>The Government is committed to pursuing a negotiated outcome which maintains our ability to export all seed to the EU and recognises that this issue is of particular concern for the seed potato industry. However, it is our duty as a responsible Government to prepare for all eventualities, including no deal, until we can be certain of the outcome of those negotiations.</p><p> </p><p> </p><p>The EU has stated in its Preparedness Notice for plant reproductive material that, in a no deal scenario, UK seed of all species will be subject to its equivalence requirements for third countries. This means that UK seed will not be marketable in the EU until the EU recognises UK processes as equivalent. Defra, with input from the devolved administrations, has made an initial application to the EU Commission for third country equivalence. More detailed information is being prepared in anticipation of discussion with the EU shortly. If approved, this would allow UK exports of seed potatoes to continue as they do now.</p> answering member constituency Camborne and Redruth answering member printed George Eustice question first answered 28/11/2018 14:43:39 answering member 3934 label Biography information for George Eustice
tabling member	4531 label Biography information for Anne-Marie Trevelyan

1011507

registered interest
date	21/11/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Breast Cancer: Drugs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the potential effect of delays in drug supply chains on access to medicines for breast cancer patients in the event that the UK leaves the EU without a deal.
tabling member constituency	Neath
tabling member printed	Christina Rees
uin	194155
answer	answer is ministerial correction date of answer 28/11/2018 answer text <p>On 23 August 2018 the Department wrote to all pharmaceutical companies that supply the United Kingdom with prescription only or pharmacy medicines from, or via, the European Union/European Economic Area, asking them to ensure they have a minimum of six weeks’ additional supply in the UK, over and above their business as usual operational buffer stocks, by 29 March 2019 in the unlikely the event that the UK were to leave the EU without a deal.</p><p> </p><p>Since then, we have received very good engagement from industry who share our aims of ensuring continuity of medicines supply for patients is maintained and able to cope with any potential delays at the border that may arise in the short term in the event of a no-deal Brexit.</p><p> </p><p>We understand medicines for breast cancer patients are vitally important to many people in this country. However, the Department recognises that through its medicines supply contingency programme, it is requesting sensitive commercial information from pharmaceutical companies. To reassure participating companies, we have committed to treating all information received confidentially, securely and to using it only for the purposes of the Department’s programme. That means not introducing information about a company, specific medicine or their supply routes into the public domain.</p> answering member constituency Wimbledon answering member printed Stephen Hammond grouped question UIN 194160 question first answered 28/11/2018 14:02:20 answering member 1585 label Biography information for Stephen Hammond
tabling member	4525 label Biography information for Christina Rees

1011508

registered interest
date	21/11/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Maternity Services: Fees and Charges
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what estimate his Department has made of the number of women who do not access maternity care because of concerns about NHS charging policies.
tabling member constituency	Birmingham, Hall Green
tabling member printed	Mr Roger Godsiff
uin	194039
answer	answer is ministerial correction date of answer 29/11/2018 answer text <p>The Department has recently reviewed the impact of changes introduced by the Amendment Regulations with a particular focus on the extent to which there are any unintended consequences for the most vulnerable. The outcomes of this review will be published in due course.</p><p> </p><p>The Department does not collect data on the number of women who do not access maternity care because of concerns about National Health Service charging policies.</p><p> </p><p>The national guidance is clear that NHS maternity treatment should always be considered as immediately necessary and provided to all patients regardless of whether or not they are entitled to receive it free of charge or there are doubts about whether they could pay if subsequently found to be chargeable under the National Health Service (Charges to Overseas Visitors) Regulations 2015, as amended.</p><p> </p><p>Providers of NHS care need to ensure that they take necessary and appropriate steps to recover the cost of providing treatment to those not entitled to NHS-funded care. National guidance recommends that providers of NHS care should consider employing the services of a debt recovery agency that specialises in the recovery of overseas debt except in relation to persons whom it is clear to the relevant body will be unable to pay.</p> answering member constituency Wimbledon answering member printed Stephen Hammond grouped question UIN 194046 194047 question first answered 29/11/2018 13:59:45 answering member 1585 label Biography information for Stephen Hammond
tabling member	304 label Biography information for Mr Roger Godsiff

1011509

registered interest
date	21/11/2018
answering body	Department for Environment, Food and Rural Affairs
answering dept id	13
answering dept short name	Environment, Food and Rural Affairs
answering dept sort name	Environment, Food and Rural Affairs
hansard heading	Air Pollution: Urban Areas
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Environment, Food and Rural Affairs, what steps he is taking to reduce levels of air pollution to legal limits in major cities.
tabling member constituency	Tooting
tabling member printed	Dr Rosena Allin-Khan
uin	194156
answer	answer is ministerial correction date of answer 29/11/2018 answer text <p>The UK continues to meet all current international air quality limits except for NO2. In July 2017 we published the NO2 Plan, backed by £3.5 billion funding, which sets out the steps we are taking to comply with NO2 limits as soon as possible. We are working intensively with local authorities, to identify measures to swiftly bring forward compliance, and support them with guidance and funding. This includes major cities outside London which are exceeding NO2 limits.</p><p> </p><p>The Mayor of London has devolved responsibility for air quality in London and has received substantial grants through the TFL grant and other grants to support improvements to modes of transport to improve air quality.</p> answering member constituency Suffolk Coastal answering member printed Dr Thérèse Coffey question first answered 29/11/2018 18:00:23 answering member 4098 label Biography information for Dr Thérèse Coffey
tabling member	4573 label Biography information for Dr Rosena Allin-Khan

1011510

registered interest
date	21/11/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	NHS: Drugs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what advice he has issued to manufacturers of general sales list medicines on whether to stockpile medicines in preparation for the UK leaving the EU without a deal; whether he plans to update that advice before the end of 2018; and if he will make a statement.
tabling member constituency	Darlington
tabling member printed	Jenny Chapman
uin	194157
answer	answer is ministerial correction date of answer 26/11/2018 answer text <p>On 23 August 2018 the Department wrote to all pharmaceutical companies that supply the United Kingdom with pharmacy (P) or prescription-only medicines (POM) from, or via, the European Union/European Economic Area (EEA), asking them to ensure they have a minimum of six weeks’ additional supply in the UK, over and above their business as usual operational buffer stocks, by 29 March 2019 in the event of a no deal EU Exit.</p><p> </p><p>Over-the-counter ‘General Sales List’ (GSL) medicines are not included in the Department’s medicines supply contingency programme. GSLs are not considered in-scope for the programme as there are multiple alternatives available should a single GSL medicine be subject to a short-term supply disruption.</p><p> </p><p>The Department is currently considering how best it may support pharmaceutical companies as part of its medicine supply contingency programme. Part of this support will include funding to provide additional capacity for the storage of P and POM medicines in the UK. A process to apply for such funding has been undertaken in recent weeks and contract agreements are imminent.</p> answering member constituency Wimbledon answering member printed Stephen Hammond grouped question UIN 194158 194159 question first answered 26/11/2018 16:08:43 answering member 1585 label Biography information for Stephen Hammond
tabling member	3972 label Biography information for Baroness Chapman of Darlington

1011511

registered interest
date	21/11/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	NHS: Drugs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what estimate he has made of the number of people presenting at NHS services because they are unable to purchase general sales list medicines for (a) themselves and (b) their children in the event that the UK leaves the EU without a deal; and if he will make a statement.
tabling member constituency	Darlington
tabling member printed	Jenny Chapman
uin	194158
answer	answer is ministerial correction date of answer 26/11/2018 answer text <p>On 23 August 2018 the Department wrote to all pharmaceutical companies that supply the United Kingdom with pharmacy (P) or prescription-only medicines (POM) from, or via, the European Union/European Economic Area (EEA), asking them to ensure they have a minimum of six weeks’ additional supply in the UK, over and above their business as usual operational buffer stocks, by 29 March 2019 in the event of a no deal EU Exit.</p><p> </p><p>Over-the-counter ‘General Sales List’ (GSL) medicines are not included in the Department’s medicines supply contingency programme. GSLs are not considered in-scope for the programme as there are multiple alternatives available should a single GSL medicine be subject to a short-term supply disruption.</p><p> </p><p>The Department is currently considering how best it may support pharmaceutical companies as part of its medicine supply contingency programme. Part of this support will include funding to provide additional capacity for the storage of P and POM medicines in the UK. A process to apply for such funding has been undertaken in recent weeks and contract agreements are imminent.</p> answering member constituency Wimbledon answering member printed Stephen Hammond grouped question UIN 194157 194159 question first answered 26/11/2018 16:08:44 answering member 1585 label Biography information for Stephen Hammond
tabling member	3972 label Biography information for Baroness Chapman of Darlington

1011512

registered interest
date	21/11/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	NHS: Drugs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether he plans to offer financial support to manufacturers of general sales list medicines for the stockpiling of medicines in preparation for the UK leaving the EU without a deal.
tabling member constituency	Darlington
tabling member printed	Jenny Chapman
uin	194159
answer	answer is ministerial correction date of answer 26/11/2018 answer text <p>On 23 August 2018 the Department wrote to all pharmaceutical companies that supply the United Kingdom with pharmacy (P) or prescription-only medicines (POM) from, or via, the European Union/European Economic Area (EEA), asking them to ensure they have a minimum of six weeks’ additional supply in the UK, over and above their business as usual operational buffer stocks, by 29 March 2019 in the event of a no deal EU Exit.</p><p> </p><p>Over-the-counter ‘General Sales List’ (GSL) medicines are not included in the Department’s medicines supply contingency programme. GSLs are not considered in-scope for the programme as there are multiple alternatives available should a single GSL medicine be subject to a short-term supply disruption.</p><p> </p><p>The Department is currently considering how best it may support pharmaceutical companies as part of its medicine supply contingency programme. Part of this support will include funding to provide additional capacity for the storage of P and POM medicines in the UK. A process to apply for such funding has been undertaken in recent weeks and contract agreements are imminent.</p> answering member constituency Wimbledon answering member printed Stephen Hammond grouped question UIN 194157 194158 question first answered 26/11/2018 16:08:43 answering member 1585 label Biography information for Stephen Hammond
tabling member	3972 label Biography information for Baroness Chapman of Darlington

1011513

registered interest
date	21/11/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Breast Cancer: Drugs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what discussions he has had with pharmaceutical companies on stockpiling breast cancer medicines to prepare for the possibility of the UK leaving the EU without a deal.
tabling member constituency	Neath
tabling member printed	Christina Rees
uin	194160
answer	answer is ministerial correction date of answer 28/11/2018 answer text <p>On 23 August 2018 the Department wrote to all pharmaceutical companies that supply the United Kingdom with prescription only or pharmacy medicines from, or via, the European Union/European Economic Area, asking them to ensure they have a minimum of six weeks’ additional supply in the UK, over and above their business as usual operational buffer stocks, by 29 March 2019 in the unlikely the event that the UK were to leave the EU without a deal.</p><p> </p><p>Since then, we have received very good engagement from industry who share our aims of ensuring continuity of medicines supply for patients is maintained and able to cope with any potential delays at the border that may arise in the short term in the event of a no-deal Brexit.</p><p> </p><p>We understand medicines for breast cancer patients are vitally important to many people in this country. However, the Department recognises that through its medicines supply contingency programme, it is requesting sensitive commercial information from pharmaceutical companies. To reassure participating companies, we have committed to treating all information received confidentially, securely and to using it only for the purposes of the Department’s programme. That means not introducing information about a company, specific medicine or their supply routes into the public domain.</p> answering member constituency Wimbledon answering member printed Stephen Hammond grouped question UIN 194155 question first answered 28/11/2018 14:02:20 answering member 1585 label Biography information for Stephen Hammond
tabling member	4525 label Biography information for Christina Rees

1011514

registered interest
date	21/11/2018
answering body	Department for Work and Pensions
answering dept id	29
answering dept short name	Work and Pensions
answering dept sort name	Work and Pensions
hansard heading	Universal Credit
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Work and Pensions, whether the maximum proportion of universal credit which can be deducted for claimant rent arrears will change as a result of Budget 2018.
tabling member constituency	Wirral West
tabling member printed	Margaret Greenwood
uin	194161
answer	answer is ministerial correction date of answer 26/11/2018 answer text <p>Although Autumn Budget 2018 announced a reduction (applying from October 2019) in the overall maximum rate of deductions from Universal Credit from 40% to 30%, the maximum proportion of Universal Credit which can be deducted for claimant rent arrears has not changed and remains between 10 and 20 per cent.</p> answering member constituency Reading West answering member printed Alok Sharma question first answered 26/11/2018 18:28:55 answering member 4014 label Biography information for Sir Alok Sharma
tabling member	4400 label Biography information for Margaret Greenwood

1011515

registered interest
date	21/11/2018
answering body	Department for Work and Pensions
answering dept id	29
answering dept short name	Work and Pensions
answering dept sort name	Work and Pensions
hansard heading	Universal Credit
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Work and Pensions, in what circumstances the repayment of an advance can be deducted from a claimant's universal credit in addition to the maximum proportion that can be deducted for other debts.
tabling member constituency	Wirral West
tabling member printed	Margaret Greenwood
uin	194162
answer	answer is ministerial correction date of answer 26/11/2018 answer text <p>There are no circumstances in which the repayment of an advance can be taken in excess of 40% of a claimant’s Universal Credit standard allowance.*</p><p> </p><p>From October 2019, we will reduce the maximum rate at which deductions can be made from a Universal Credit award from 40% to 30% of the standard allowance. This will ensure that those on Universal Credit are supported to repay debts in a more sustainable and manageable way. From October 2021, we will also increase the period over which advances will be recovered, from 12 to 16 months.</p><p> </p><p>* The addition of a subsequent deduction such as for rent, gas or electricity arrears may take the overall level of deductions to over 40% in a small number of cases. In these circumstances the advance repayments do not themselves take the claimant over the threshold, rather the additional deductions are made to protect claimant welfare by preventing disconnection or eviction.</p> answering member constituency Reading West answering member printed Alok Sharma question first answered 26/11/2018 17:30:26 answering member 4014 label Biography information for Sir Alok Sharma
tabling member	4400 label Biography information for Margaret Greenwood